Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding
Following the failure of PF-07081532 , on November 6th, Sosei announced that in Pfizer's recently released third-quarter company presentation, Pfizer officially included the PF-06954522 project in the latest Phase 1 clinical study plan
Potential benefits Based on available literature, clinical trials, and anecdotal/clinical practice reports, these are the benefits most often cited: Fat loss / body composition improvement Reduction in overall body fat, especially subcutaneous & visceral fat
The selectivity for beta-3 receptors explains the favorable safety profile compared to non-selective beta agonists that cause cardiovascular stimulation and other systemic effects
C.RahimN
